UNITED STATES
SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549
FORM 8-K/A
CURRENT REPORT
PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934
Date of Report (Date of earliest event reported): October 27, 2003
ENCORE MEDICAL CORPORATION
(Exact name of registrant as specified in charter)
Delaware
(State or Other Jurisdiction of Incorporation)
| 000-26538 | | 65-0572565 |
| (Commission File Number) | | (IRS Employer Identification No.) |
| |
| 9800 Metric Blvd., Austin, Texas | | 78758 |
| (Address of Principal Executive Offices) | | (Zip Code) |
(512) 832-9500
(Registrant’s telephone number, including area code)
No Change
(Former Name or Former Address, if Changed Since Last Report)
FILING NOTE:
This Form 8-K/A and its related Exhibits are filed to correct the Item number under which certain information was filed previously on Form 8-K on October 27, 2003.
Item 5 – Other Events and Required FD Disclosure
On October 27, 2003, Encore Medical Corporation (the “Company”) issued a press release, entitled “Encore Medical Reports Record Third Quarter Revenue and Operating Income – Sales in All Divisions Increase Over Prior Year Results.” A copy of this press release is attached hereto as Exhibit 99.1 and is hereby incorporated herein by reference.
Item 7 – Financial Statements, Pro Forma Financial Statements and Exhibits
Exhibit
Number
| | Description
|
| |
| 99.1 | | Press Release, dated October 27, 2003, entitled “Encore Medical Corporation Files Equity Offering” |
| |
| 99.2 | | Press Release, dated October 27, 2003, entitled “Encore Medical Reports Record Third Quarter Revenue and Operating Income – Sales in All Divisions Increase Over Prior Year Results” |
Item 12 – Results of Operations and Financial Condition
On October 27, 2003, the Company issued a press release reporting its financial results for the quarter ended September 27, 2003. A copy of the Company’s press release is attached hereto as Exhibit 99.2 and is hereby incorporated herein by reference.
The information in this Item 12 and Exhibit 99.2 attached hereto shall be deemed “furnished” and shall not be deemed “filed” for purposes of Section 18 of the Securities Exchange Act of 1934, as amended, or otherwise subject to the liabilities of that section, nor shall it be deemed incorporated by reference in any Company filing under the Securities Act of 1933, as amended.
2
SIGNATURES
Pursuant to the requirements of the Securities Exchange Act of 1934, the Registrant has duly caused this report to be signed on its behalf by the undersigned thereunto duly authorized.
| | | | | | | ENCORE MEDICAL CORPORATION |
| | | |
| Date: October 28, 2003 | | | | By: | | /s/ Harry L. Zimmermann |
| | | | | |
|
| | | | | | | | | Harry L. Zimmermann Executive Vice President – General Counsel |
3
Exhibit Index
Exhibit No.
| | Description of Exhibit
|
| |
| 99.1 | | Press Release, dated October 27, 2003, entitled “Encore Medical Corporation Files Equity Offering” |
| |
| 99.2 | | Press Release, dated October 27, 2003, entitled “Encore Medical Reports Record Third Quarter Revenue and Operating Income – Sales in All Divisions Increase Over Prior Year Results” |
4
